Dr. Priyank P. Patel
Claim this profileCarle Cancer Center
About Priyank P. Patel
Education:
- Obtained MD from the University of Illinois College of Medicine at Peoria in 2015.
- Completed Residency in Radiation Oncology at the University of Iowa Hospitals and Clinics in 2020.
- Finished Fellowship in Stereotactic Body Radiotherapy (SBRT) and Stereotactic Radiosurgery (SRS) at the University of California, San Francisco in 2021.
Experience:
- Specializes in Radiation Oncology, Stereotactic Body Radiotherapy (SBRT), and Stereotactic Radiosurgery (SRS).
- Associated with Carle Cancer Center.
Area of expertise
Lung Cancer
Priyank P. Patel has run 9 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Priyank P. Patel has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Carle Cancer Center
Carle Physician Group-Effingham
Clinical Trials Priyank P. Patel is currently running
Osimertinib
for Non-Small Cell Lung Cancer
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting
1 award
Phase 2
42 criteria
Combination Therapy
for Multiple Myeloma
This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.
Recruiting
2 awards
Phase 3
32 criteria
More about Priyank P. Patel
Clinical Trial Related
7 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 11 Active Clinical Trials
Treatments Priyank P. Patel has experience with
- Carboplatin
- Nivolumab
- Atezolizumab
- Cisplatin
- Pembrolizumab
- Venetoclax
Breakdown of trials Priyank P. Patel has run
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Priyank P. Patel specialize in?
Priyank P. Patel focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Priyank P. Patel currently recruiting for clinical trials?
Yes, Priyank P. Patel is currently recruiting for 11 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Priyank P. Patel has studied deeply?
Yes, Priyank P. Patel has studied treatments such as Carboplatin, Nivolumab, Atezolizumab.
What is the best way to schedule an appointment with Priyank P. Patel?
Apply for one of the trials that Priyank P. Patel is conducting.
What is the office address of Priyank P. Patel?
The office of Priyank P. Patel is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.